Pharmacotherapy of migraine

V. Demarin, A. Lovrencic-Huzjan, Tatjana Rundek, S. Podobnik-Sarkanji

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Migraine is a frequent disease, which makes the patients impossible to function normally. The exact mechanism of the pathogenesis of attack is not known, although a few theories do exist. One is the vascular theory, and the other the theory of 'neurogenic inflammation'. 5-HT is an important neurotransmitter in the pathogenesis of migraine attack. Stress is one of the important risk factors for initiating the attack. Treatment call be started by eliminating the possible trigger factor for the development of the attack. The acute attack can be treated by different drugs: non-steroid antiinflammatory drugs (NSAIDs) including acetylsalicylic acid and paracetamol, mostly combined with an antiemetic; ergot preparations, which are widely used but have not proved their efficacy in controlled clinical trials and can lead to addiction and 'ergot-dependent headache'; sumatriptan, which is a selective 5-HT1D receptor agonist, and is a highly selective drug for the treatment of migraine attacks. In patients with two or more attacks per month prophylactic treatment should be started. For migraine prevention different 5-HT2 receptor antagonists with 5-HT1C activity may be used: beta adrenergic receptor blockers, antidepressants, pizotifen and methysergide. Various relaxation techniques and acupuncture may be used as non-drug treatment.

Original languageEnglish
Pages (from-to)81-89
Number of pages9
JournalActa Clinica Croatica
Volume34
Issue number2
StatePublished - Jan 1 1995
Externally publishedYes

Fingerprint

Migraine Disorders
Drug Therapy
Pizotyline
Receptor, Serotonin, 5-HT1D
Pharmaceutical Preparations
Neurogenic Inflammation
Serotonin 5-HT1 Receptor Agonists
Relaxation Therapy
Serotonin 5-HT2 Receptor Antagonists
Sumatriptan
Methysergide
Adrenergic beta-Antagonists
Antiemetics
Receptors, Adrenergic, beta
Controlled Clinical Trials
Acupuncture
Therapeutics
Acetaminophen
Antidepressive Agents
Aspirin

Keywords

  • Migraine
  • Serotonin
  • Sumatriptan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Demarin, V., Lovrencic-Huzjan, A., Rundek, T., & Podobnik-Sarkanji, S. (1995). Pharmacotherapy of migraine. Acta Clinica Croatica, 34(2), 81-89.

Pharmacotherapy of migraine. / Demarin, V.; Lovrencic-Huzjan, A.; Rundek, Tatjana; Podobnik-Sarkanji, S.

In: Acta Clinica Croatica, Vol. 34, No. 2, 01.01.1995, p. 81-89.

Research output: Contribution to journalArticle

Demarin, V, Lovrencic-Huzjan, A, Rundek, T & Podobnik-Sarkanji, S 1995, 'Pharmacotherapy of migraine', Acta Clinica Croatica, vol. 34, no. 2, pp. 81-89.
Demarin V, Lovrencic-Huzjan A, Rundek T, Podobnik-Sarkanji S. Pharmacotherapy of migraine. Acta Clinica Croatica. 1995 Jan 1;34(2):81-89.
Demarin, V. ; Lovrencic-Huzjan, A. ; Rundek, Tatjana ; Podobnik-Sarkanji, S. / Pharmacotherapy of migraine. In: Acta Clinica Croatica. 1995 ; Vol. 34, No. 2. pp. 81-89.
@article{00ecb9cd3dab4355b3d9b1bca158c51e,
title = "Pharmacotherapy of migraine",
abstract = "Migraine is a frequent disease, which makes the patients impossible to function normally. The exact mechanism of the pathogenesis of attack is not known, although a few theories do exist. One is the vascular theory, and the other the theory of 'neurogenic inflammation'. 5-HT is an important neurotransmitter in the pathogenesis of migraine attack. Stress is one of the important risk factors for initiating the attack. Treatment call be started by eliminating the possible trigger factor for the development of the attack. The acute attack can be treated by different drugs: non-steroid antiinflammatory drugs (NSAIDs) including acetylsalicylic acid and paracetamol, mostly combined with an antiemetic; ergot preparations, which are widely used but have not proved their efficacy in controlled clinical trials and can lead to addiction and 'ergot-dependent headache'; sumatriptan, which is a selective 5-HT1D receptor agonist, and is a highly selective drug for the treatment of migraine attacks. In patients with two or more attacks per month prophylactic treatment should be started. For migraine prevention different 5-HT2 receptor antagonists with 5-HT1C activity may be used: beta adrenergic receptor blockers, antidepressants, pizotifen and methysergide. Various relaxation techniques and acupuncture may be used as non-drug treatment.",
keywords = "Migraine, Serotonin, Sumatriptan",
author = "V. Demarin and A. Lovrencic-Huzjan and Tatjana Rundek and S. Podobnik-Sarkanji",
year = "1995",
month = "1",
day = "1",
language = "English",
volume = "34",
pages = "81--89",
journal = "Acta Clinica Croatica",
issn = "0353-9466",
publisher = "Klinicka Bolnica Sestre Milosrdnice",
number = "2",

}

TY - JOUR

T1 - Pharmacotherapy of migraine

AU - Demarin, V.

AU - Lovrencic-Huzjan, A.

AU - Rundek, Tatjana

AU - Podobnik-Sarkanji, S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Migraine is a frequent disease, which makes the patients impossible to function normally. The exact mechanism of the pathogenesis of attack is not known, although a few theories do exist. One is the vascular theory, and the other the theory of 'neurogenic inflammation'. 5-HT is an important neurotransmitter in the pathogenesis of migraine attack. Stress is one of the important risk factors for initiating the attack. Treatment call be started by eliminating the possible trigger factor for the development of the attack. The acute attack can be treated by different drugs: non-steroid antiinflammatory drugs (NSAIDs) including acetylsalicylic acid and paracetamol, mostly combined with an antiemetic; ergot preparations, which are widely used but have not proved their efficacy in controlled clinical trials and can lead to addiction and 'ergot-dependent headache'; sumatriptan, which is a selective 5-HT1D receptor agonist, and is a highly selective drug for the treatment of migraine attacks. In patients with two or more attacks per month prophylactic treatment should be started. For migraine prevention different 5-HT2 receptor antagonists with 5-HT1C activity may be used: beta adrenergic receptor blockers, antidepressants, pizotifen and methysergide. Various relaxation techniques and acupuncture may be used as non-drug treatment.

AB - Migraine is a frequent disease, which makes the patients impossible to function normally. The exact mechanism of the pathogenesis of attack is not known, although a few theories do exist. One is the vascular theory, and the other the theory of 'neurogenic inflammation'. 5-HT is an important neurotransmitter in the pathogenesis of migraine attack. Stress is one of the important risk factors for initiating the attack. Treatment call be started by eliminating the possible trigger factor for the development of the attack. The acute attack can be treated by different drugs: non-steroid antiinflammatory drugs (NSAIDs) including acetylsalicylic acid and paracetamol, mostly combined with an antiemetic; ergot preparations, which are widely used but have not proved their efficacy in controlled clinical trials and can lead to addiction and 'ergot-dependent headache'; sumatriptan, which is a selective 5-HT1D receptor agonist, and is a highly selective drug for the treatment of migraine attacks. In patients with two or more attacks per month prophylactic treatment should be started. For migraine prevention different 5-HT2 receptor antagonists with 5-HT1C activity may be used: beta adrenergic receptor blockers, antidepressants, pizotifen and methysergide. Various relaxation techniques and acupuncture may be used as non-drug treatment.

KW - Migraine

KW - Serotonin

KW - Sumatriptan

UR - http://www.scopus.com/inward/record.url?scp=0029142943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029142943&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029142943

VL - 34

SP - 81

EP - 89

JO - Acta Clinica Croatica

JF - Acta Clinica Croatica

SN - 0353-9466

IS - 2

ER -